Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Registry facet

Defined terms in the registry — page 4

195 documents of type defined term.

Documents

195 documents · page 4 of 5
  • CEI-GT-121Defined term2026-q3

    A single molecule activating three receptors, in this set GIP, GLP-1 and glucagon. The glucagon component contributes an energy-expenditure effect and a hepatic effect…

    30 Jul 2026
  • CEI-GT-122Defined term2026-q3

    A pancreatic hormone co-secreted with insulin that slows gastric emptying and promotes satiation through the area postrema. Amylin analogues act on a mechanism largely…

    30 Jul 2026
  • CEI-GT-123Defined term2026-q3

    A compound activating amylin and calcitonin receptors, producing meal-related satiation. Combined with an incretin agonist in at least one fixed-combination product in…

    30 Jul 2026
  • CEI-GT-124Defined term2026-q3

    Attachment of a fatty-acid chain to a peptide, most often to mediate reversible albumin binding and thereby extend half-life. The structural feature underlying weekly…

    30 Jul 2026
  • CEI-GT-125Defined term2026-q3

    A circumventricular structure lacking a complete blood–brain barrier, accessible to circulating peptides and central to both the satiety and the nausea effects of this…

    30 Jul 2026
  • CEI-GT-126Defined term2026-q3

    The rate at which stomach contents pass into the duodenum. Delayed by GLP-1 receptor agonism, with partial attenuation on continued dosing, and relevant to both…

    30 Jul 2026
  • CEI-GT-127Defined term2026-q3

    Breakdown of a peptide by proteases, principally dipeptidyl peptidase-4 for incretins. Resistance is engineered by substitution at the cleavage site.

    30 Jul 2026
  • CEI-GT-128Defined term2026-q3

    Dipeptidyl peptidase-4, the protease that cleaves native glucagon-like peptide-1 within minutes. Every long-acting analogue in this set is protected against it…

    30 Jul 2026
  • CEI-GT-129Defined term2026-q3

    Separation on a hydrophobic stationary phase under an acidified aqueous–organic gradient, with ultraviolet detection at 214 nanometres. The Institute’s reference method…

    30 Jul 2026
  • CEI-GT-130Defined term2026-q3

    The area of the main peak as a percentage of total integrated area under stated conditions. A relative measure that assumes comparable molar absorptivity across species…

    30 Jul 2026
  • CEI-GT-131Defined term2026-q3

    The retention-time range over which peak areas are summed. Changing the window changes the reported purity without changing the material, which is why the Institute…

    30 Jul 2026
  • CEI-GT-132Defined term2026-q3

    The programmed change in mobile-phase composition over a chromatographic run. A shallow gradient resolves close-eluting species that a steep gradient co-elutes, and the…

    30 Jul 2026
  • CEI-GT-133Defined term2026-q3

    A property of a method that separates the intact compound from its degradation products, demonstrated by forced-degradation study. A purity method that is not…

    30 Jul 2026
  • CEI-GT-134Defined term2026-q3

    Deliberate exposure of a sample to heat, light, acid, base and oxidant to generate degradation products against which a method’s specificity is demonstrated.

    30 Jul 2026
  • CEI-GT-135Defined term2026-q3

    A set of criteria confirmed at the time of analysis establishing that the chromatographic system is performing adequately. A result obtained on a system failing…

    30 Jul 2026
  • CEI-GT-136Defined term2026-q3

    The mass fraction of a lyophilisate that is peptide, the remainder being water, counter-ion and residual solvent. Determined by amino-acid analysis or nitrogen…

    30 Jul 2026
  • CEI-GT-137Defined term2026-q3

    The sum of peptide content, water content and counter-ion content, which should approach one hundred per cent. A certificate that does not permit a mass balance to be…

    30 Jul 2026
  • CEI-GT-138Defined term2026-q3

    The ion paired with a charged peptide, most often trifluoroacetate or acetate from purification. Can constitute a substantial fraction of the mass of a basic peptide and…

    30 Jul 2026
  • CEI-GT-139Defined term2026-q3

    The counter-ion most commonly introduced by reverse-phase purification with trifluoroacetic acid. Quantified by ion chromatography or fluorine nuclear magnetic…

    30 Jul 2026
  • CEI-GT-140Defined term2026-q3

    The reference method for water content, based on the stoichiometric reaction of water with iodine and sulfur dioxide. The only water determination the Institute accepts…

    30 Jul 2026
  • CEI-GT-141Defined term2026-q3

    The mass fraction of a lyophilisate that is water. Substantial for a hygroscopic peptide and a direct subtraction from delivered peptide mass.

    30 Jul 2026
  • CEI-GT-142Defined term2026-q3

    Determination of mass-to-charge ratio, used to confirm identity. For a peptide, deconvolution of the multiply charged envelope should return an average mass within a…

    30 Jul 2026
  • CEI-GT-143Defined term2026-q3

    The mass calculated using the most abundant isotope of each element. Requires high resolving power to determine for a peptide of several kilodaltons, and is not…

    30 Jul 2026
  • CEI-GT-144Defined term2026-q3

    The mass calculated using isotope-averaged atomic weights, and the value returned by deconvolution of an electrospray charge envelope at moderate resolution.

    30 Jul 2026
  • CEI-GT-145Defined term2026-q3

    A second analytical method resting on a different physical principle from the first. Identity confirmed by two orthogonal methods is materially stronger than identity…

    30 Jul 2026
  • CEI-GT-146Defined term2026-q3

    Confirmation that the material is the substance claimed. Retention-time correspondence alone is weak evidence of identity; mass-spectrometric confirmation of the…

    30 Jul 2026
  • CEI-GT-147Defined term2026-q3

    Enzymatic digestion followed by chromatographic and mass-spectrometric analysis of the resulting fragments, used to confirm sequence. Rarely performed on research-supply…

    30 Jul 2026
  • CEI-GT-148Defined term2026-q3

    Impurities structurally related to the target peptide, arising from synthesis or degradation. Reported by name and retention time on a complete certificate and as a…

    30 Jul 2026
  • CEI-GT-149Defined term2026-q3

    An impurity lacking one or more residues, arising from incomplete coupling during synthesis. Often close-eluting and detectable only by mass spectrometry.

    30 Jul 2026
  • CEI-GT-150Defined term2026-q3

    Conversion of asparagine or glutamine to the corresponding acid, adding one dalton and altering charge. A principal storage-related degradation route for peptides in…

    30 Jul 2026
  • CEI-GT-151Defined term2026-q3

    Conversion of aspartate to isoaspartate through a succinimide intermediate, producing a species of identical mass and different retention. Undetectable by mass alone.

    30 Jul 2026
  • CEI-GT-152Defined term2026-q3

    Addition of oxygen to methionine, tryptophan or cysteine, adding sixteen daltons. Accelerated by peroxide, light and metal ions.

    30 Jul 2026
  • CEI-GT-153Defined term2026-q3

    Association of peptide molecules into higher-order species, driven by agitation, freeze–thaw cycling and proximity to the isoelectric point. Not detected by a…

    30 Jul 2026
  • CEI-GT-154Defined term2026-q3

    Separation by hydrodynamic radius, the standard method for aggregate determination. Reported on no certificate in the Institute’s sampled set.

    30 Jul 2026
  • CEI-GT-155Defined term2026-q3

    Lipopolysaccharide from Gram-negative bacterial cell walls, pyrogenic on parenteral administration. Determined by a lysate-based or recombinant assay against a dose- and…

    30 Jul 2026
  • CEI-GT-156Defined term2026-q3

    The absence of viable microorganisms, demonstrated by a compendial test on the finished presentation. Distinct from endotoxin content, which persists after sterilisation.

    30 Jul 2026
  • CEI-GT-157Defined term2026-q3

    The proportion of residues in the intended stereochemical configuration. Racemisation during synthesis produces species of identical mass and identical reverse-phase…

    30 Jul 2026
  • CEI-GT-158Defined term2026-q3

    The lowest concentration at which a determination can be made with stated precision and accuracy. An impurity below the limit is not absent; it is unquantified.

    30 Jul 2026
  • CEI-GT-159Defined term2026-q3

    The lowest concentration at which the presence of a species can be distinguished from noise. Lower than the limit of quantitation and not a basis for a numerical result.

    30 Jul 2026
  • CEI-GT-160Defined term2026-q3

    A characterised material with an assigned content value against which a determination is made. A result obtained without a named standard reports an area percentage…

    30 Jul 2026

page 4 of 5

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.